Phase IAndrogen Modulator
Compound 61710
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061710
Risk Class
HIGH
Last Audit
Jun 24, 2108
Research Abstract
Androgen Modulator candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61710 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase i with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061710 with updates logged 2108-06-24.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61710Androgen Modulator Program 61710
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061710
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61710